Objective:
Sepsis causes millions of deaths on a global scale annually. Activation of
peptidylarginine deiminase (PAD)
enzymes in
sepsis causes citrullination of
histones, which results in neutrophil extracellular trap formation and
sepsis progression. This study evaluates pan-PAD inhibitor,
Cl-amidine, in a model of
lipopolysaccharide (LPS)-induced endotoxic
shock in rabbits. We hypothesized that
Cl-amidine would improve survival and attenuate kidney injury. Methods: In the survival model, rabbits were injected injected intravenously with 1 mg/kg of LPS, and then randomly assigned either to receive
dimethyl sulfoxide (
DMSO; 1 mcL/g) or
Cl-amidine (10 mg/kg diluted in 1 mcL/g
DMSO). They were then monitored for 14 days to evaluate survival. In the non-survival experiment, the same insult and treatment were administered, however; the animals were euthanized 12 hours after LPS injection for kidney harvest.
Acute kidney injury (AKI) scoring was performed by a histopathologist who was blinded to the group assignment. Serial blood samples were also collected and compared. Results: Rabbits that received
Cl-amidine had a higher survival (72%) compared with the rabbits that received
DMSO (14%; p < 0.05).
Cl-amidine-treated rabbits had lower (p < 0.05) histopathologic AKI scores, as well as plasma
creatinine and blood
urea nitrogen (BUN) levels 12 hours after insult. Conclusions: Pan-PAD inhibitor
Cl-amidine improves survival and attenuates kidney injury in LPS-induced endotoxic
shock in rabbits.